Phreesia and New Jersey Urology Partner to Standardize Intake and Improve Patient Experience
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Phreesia Inc. (PHR) PT Raised to $60 at Cantor Fitzgerald
March 31, 2021 12:08 PM EDTCantor Fitzgerald analyst Steven Halper raised the price target on Phreesia Inc. (NYSE: PHR) to $60.00 (from $55.00) while maintaining an Overweight rating.
The analyst commented, "We reiterate our Overweight rating on PHR shares and increase our price target to $60 from $55. After the market close... More
